Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.
about
Cardiac regeneration and diabetesConsiderations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytesCardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cellsAllogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy31P NMR 2D Mapping of Creatine Kinase Forward Flux Rate in Hearts with Postinfarction Left Ventricular Remodeling in Response to Cell TherapyTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicineAllogeneic pASC transplantation in humanized pigs attenuates cardiac remodeling post-myocardial infarction.The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.Quantitative Proteomics and Immunohistochemistry Reveal Insights into Cellular and Molecular Processes in the Infarct Border Zone One Month after Myocardial Infarction.Embryonic stem cell-derived cardiac myocytes are not ready for human trialsNew vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature.Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survivalDerivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.Metabolic efficiency promotes protection from pressure overload in hearts expressing slow skeletal troponin I.Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.On the theoretical limits of detecting cyclic changes in cardiac high-energy phosphates and creatine kinase reaction kinetics using in vivo ³¹P MRS.Pluripotent Stem Cells and Other Innovative Strategies for the Treatment of Ocular Surface Diseases.Myocardial ATP hydrolysis rates in vivo: a porcine model of pressure overload-induced hypertrophyXenotransplantation of Bone Marrow-Derived Human Mesenchymal Stem Cell Sheets Attenuates Left Ventricular Remodeling in a Porcine Ischemic Cardiomyopathy Model.Quantitative proteomics reveals differential regulation of protein expression in recipient myocardium after trilineage cardiovascular cell transplantation.Transmurally differentiated measurement of ATP hydrolysis rates in the in vivo porcine hearts.A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.The origin of human mesenchymal stromal cells dictates their reparative properties.Implantation of a Poly-L-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial InfarctionPatching the heart: cardiac repair from within and outsideCardiac tissue engineering: renewing the arsenal for the battle against heart disease.Matrix revisited: mechanisms linking energy substrate metabolism to the function of the heart.Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges.Cardiac Tissue Vascularization: From Angiogenesis to Microfluidic Blood Vessels.Engineered Tissue Patch for Cardiac Cell TherapyGenerating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases.New strategies for improving stem cell therapy in ischemic heart disease.Striated muscle function, regeneration, and repairSUV39H1 mediated SIRT1 trans-repression contributes to cardiac ischemia-reperfusion injury.Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases.CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.Mechanisms of cell therapy for clinical investigations: an urgent need for large-animal models.Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application.Lactate Promotes Synthetic Phenotype in Vascular Smooth Muscle Cells.Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering.
P2860
Q21195758-15E1FB61-5573-4D45-973D-38A17D7C80A3Q26865173-8D15F277-1770-4002-9530-EB3904CFD913Q27303668-97DF8743-7AE6-4132-B285-3767E20E245FQ27322954-E9A496DB-2C54-4D2C-995B-34A0C4534D21Q27324170-436A2E02-E205-46D2-80FF-16E80418A018Q28076397-2F45DE26-45AD-4256-858B-B6EE97190351Q30356542-11DA8CA8-F138-44BF-8797-3EA71C304A15Q33748399-9EB0FEB7-D701-406E-B3B0-286F60DE8828Q33834464-047FDF1C-87C3-48E4-B089-7A7E24691777Q34048693-756C4488-2B35-4D71-AC80-02BCB3194648Q34422460-ABE5A630-8869-4FB1-AD72-4F6AB54238B6Q34668028-B39399F6-18C2-4B81-8319-51A5B97A5DF8Q35002134-AA387F11-B003-49F3-8460-BA2BE4C4FF2EQ35002176-453F01D7-4F10-4760-89D0-C2CAAEBE3A01Q35087066-ED5987CD-1013-45CA-98B9-9F25A538A47AQ35610643-97884C6D-ACED-4E90-812F-B115493129F9Q35896756-AEC60E2F-5675-4F86-8F8A-9203566066AFQ35916751-0516F7C2-F0BB-4CB0-825F-E732712FB593Q35927940-FEFAA3E4-0BA4-4ADD-BD61-C61B0DFEA4AAQ36403046-6B40190A-2683-4C31-B976-E141BC3DFBF7Q36803252-B170337F-8DF3-40B8-99CF-64883CC8AC2AQ36973427-BB8FD6AD-E0AE-46A8-8DB4-6C978C0BC381Q37328729-0021896C-ABB3-4BC6-B8F9-14A9865B2894Q37662785-D27DB81E-D37B-41B8-93E1-8E82D9B05809Q38136924-E3C94F1E-2934-4318-A176-200A8126EBE1Q38172390-76FB35C8-6436-4727-B722-1F2ADDE18E55Q38187952-05254BFC-D183-4D7D-9261-A7280EE29370Q38203865-42FC63DB-129C-4653-B7A7-A49649E06616Q38206983-41E115D6-FCD8-401B-895B-A7238B71D890Q38540150-C3928ECF-420E-48E8-B508-05258BFED052Q38541742-48A920A7-20A4-4E6A-88F4-3C2153BAB881Q38804978-34C485DB-B478-45C5-BC86-BB5D1DF61CF0Q38857890-75DFAC5B-CD83-4AB1-B46D-F2DDBF1E7D81Q38922001-A7809E5E-4252-4E8A-B5C0-2C444D002670Q39329517-6761F1FF-C168-40E9-8B2E-24BE371AEF2FQ41919795-E59C4799-90B5-452B-80A7-34F1BC6E41F2Q42918845-1D56390B-3F12-446E-965A-DCF66A8EC3B3Q47270959-DBCB1F8D-583C-4803-9345-00FBDB6C5AFEQ47578992-6548ECDD-CD40-4311-B231-9A5006975EAAQ47837438-E85B6F15-61B1-4BDE-97AF-5C116A03A220
P2860
Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Functional consequences of hum ...... ith postinfarction remodeling.
@ast
Functional consequences of hum ...... ith postinfarction remodeling.
@en
type
label
Functional consequences of hum ...... ith postinfarction remodeling.
@ast
Functional consequences of hum ...... ith postinfarction remodeling.
@en
prefLabel
Functional consequences of hum ...... ith postinfarction remodeling.
@ast
Functional consequences of hum ...... ith postinfarction remodeling.
@en
P2093
P2860
P1433
P1476
Functional consequences of hum ...... with postinfarction remodeling
@en
P2093
Cory Swingen
J Thomas Vaughan
Jianyi Zhang
Jinfeng Tian
Liying Zhang
Michael Lepley
Pengyuan Zhang
Qiang Xiong
P2860
P304
P356
10.1161/CIRCULATIONAHA.112.000641
P407
P577
2013-01-31T00:00:00Z